Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 7/20 | 0.42 |
| ▸ | ESR1 | P03372 | 6/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31490395 | 1.00 | CYP3A4 (0.42) | CYP3A4ALOX15CHRM1MAOATBXA2R | |
| SCHEMBL1928567 | 0.83 | ESR2 (0.48) | CYP3A4ALOX15CHRM1MAOATBXA2R | |
| SCHEMBL5748285 | 0.81 | ACHE (0.45) | CYP3A4ALOX15CHRM1MAOATBXA2R | |
| SCHEMBL2481401 | 0.80 | HSD17B10 (0.36) | CYP3A4ALOX15ESR2ESR1HSD17B10 | |
| SCHEMBL9006588 | 0.78 | TYR (0.41) | CYP3A4ALOX15ESR2ESR1HSD17B10 | |
| SCHEMBL11092955 | 0.76 | NR1H2 (0.52) | CYP3A4ALOX15CHRM1MAOATBXA2R | |
| SCHEMBL11731334 | 0.76 | CYP3A4 (0.41) | CYP3A4ALOX15CHRM1MAOATBXA2R | |
| SCHEMBL11066678 | 0.76 | ESR2 (0.38) | CYP3A4ALOX15CHRM1MAOATBXA2R | |
| SCHEMBL735441 | 0.75 | HSD17B10 (0.44) | CYP3A4ALOX15TAS1R3TAS1R1HSD17B10 | |
| SCHEMBL31417935 | 0.74 | ALOX15 (0.35) | CYP3A4ALOX15ESR2ESR1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 525 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4717035-A1 | HYBRID COMMUNICATION SYSTEM AND COMMUNICATION METHOD | Shenzhen TCL New Technology Co., Ltd (CN) | 2026-04-01 | — | — | EP | claimed |
| EP-3280150-B1 | TRANSMISSION METHOD, RECEPTION METHOD, TRANSMISSION DEVICE AND RECEPTION DEVICE | PANASONIC IP CORP AMERICA (US) | 2026-01-21 | — | — | EP | claimed |
| WO-2024239247-A1 | HYBRID COMMUNICATION SYSTEM AND COMMUNICATION METHOD | SHENZHEN TCL NEW TECHNOLOGY CO., LTD. (CN) | 2024-11-28 | — | — | WO | claimed |
| EP-3840313-B1 | METHOD AND APPARATUS FOR PACKET TRANSMISSION SUPPORTING DOWNLOADING AND STREAMING | SAMSUNG ELECTRONICS CO LTD (KR) | 2024-11-27 | — | — | EP | claimed |
| US-12106747-B2 | Receiver, signaling device, and method for receiving emergency information time information | SHARP KABUSHIKI KAISHA (JP) | 2024-10-01 | — | — | US | claimed |
| CN-113475087-B | Transmitting and receiving method and transmitting and receiving device | 海信视像科技股份有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-117837151-A | Streaming media data transmission method and device and terminal equipment | 深圳TCL新技术有限公司 | 2024-04-05 | — | — | CN | claimed |
| EP-3610651-B1 | METHOD AND APPARATUS FOR PROVIDING BROADCAST SERVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2024-03-13 | — | — | EP | claimed |
| EP-3217606-B1 | TRANSMISSION DEVICE, TRANSMISSION METHOD, RECEPTION DEVICE, AND RECEPTION METHOD | SONY GROUP CORP (JP) | 2023-11-29 | — | — | EP | claimed |
| EP-4284007-A2 | TRANSMISSION DEVICE, TRANSMISSION METHOD, RECEPTION DEVICE, AND RECEPTION METHOD | Sony Group Corporation (JP) | 2023-11-29 | — | — | EP | claimed |
| US-6451830-B1 | Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. | 2002-09-17 | — | — | US | claimed |
| US-6448295-B1 | TREATING CARDIOVASCULAR DISEASE; ATHEROSCLEROSIS, DYSLIPIDEMA HYPERCHOLESTEROLAEMIA; DECREASING CONCENTRATIONS OF LOW DENSITY LIPOPROTEIN AND RAISING LEVEL OF HIGH DENSITY LIPOPROTEIN | G.D. SEARLE & CO. | 2002-09-10 | — | — | US | claimed |
| US-20020120011-A1 | Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity | SIKORSKI JAMES A (US) | 2002-08-29 | — | — | US | claimed |
| US-20010018446-A1 | Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. (US) | 2001-08-30 | — | — | US | claimed |
| EP-1115695-A1 | (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(N+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | Monsanto Company (US) | 2001-07-18 | — | — | EP | claimed |
| EP-1115693-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | Monsanto Company (US) | 2001-07-18 | — | — | EP | claimed |
| EP-1115694-A1 | SUBSTITUTED N-ALIPHATIC-N-AROMATIC (TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | Monsanto Company (US) | 2001-07-18 | — | — | EP | claimed |
| WO-2000018724-A1 | (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(n+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | MONSANTO COMPANY (US) | 2000-04-06 | — | — | WO | claimed |
| WO-2000018723-A1 | SUBSTITUTED N-ALIPHATIC-N-AROMATIC TERTIARY-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | MONSANTO COMPANY (US) | 2000-04-06 | — | — | WO | claimed |
| WO-2000018721-A1 | SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL TERTIARY-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | MONSANTO COMPANY (US) | 2000-04-06 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010018446-A1 | Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | CETP, DBI, MTTP | CYP3A4 2162/4885ALOX15 1545/4885CHRM1 3159/4885 |
| US-20020120011-A1 | Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity | CETP, PCTP, DBI | CYP3A4 3355/4885ALOX15 1770/4885CHRM1 4348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.